In this study, we have demonstrated that the serum CXCL13 levels were markedly increased in both IBD patients (Figure 1A) and mice colitis models (Figure 3A), and its expression level was positively correlated with the severity of inflammatory response (Figures 1B–D). This evidence concerns the gene CXCL13 and inflammatory bowel disease.